Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep-wake and circadian behavior in brain-specific sirtuin 1 knockout mice and effects of nicotinamide mononucleotide supplementation.

Scientific reports·2026
Same author

Homocysteine increases phosphorylation and aggregation of α-synuclein.

Journal of clinical biochemistry and nutrition·2026
Same author

Hypocretin-1/ Orexin-A fragment1-16 as a potential surrogate marker for diagnosing narcolepsy type 1.

Sleep·2026
Same author

PRDX4 Potentially Serves as an Independent Marker for Early Recurrence of Oral Squamous Cell Carcinoma.

Anticancer research·2026
Same author

Combined assessment of stromal tumor infiltrating lymphocytes and tumor peroxiredoxin 4 expression improved prognostic stratification in postoperative pancreatic cancer patients.

Diagnostic pathology·2026
Same author

Effects of Sleepwear Incorporating a DPV576 Functional Polyester Fabric on Wearable ECG-Derived Sleep Consolidation: A Randomized Two-Period Crossover Study Under Free-Living Conditions.

Sensors (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 4, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Armodafinil for excessive daytime sleepiness.

Seiji Nishino1, Masashi Okuro

  • 1Sleep and Circadian Neurobiology Laboratory, Center for Narcolepsy, Stanford University School of Medicine, Palo Alto, CA 94304-5489, USA. nishino@stanford.edu

Drugs of Today (Barcelona, Spain : 1998)
|July 4, 2008
PubMed
Summary

Armodafinil, a wake-promoting agent, offers longer-lasting effects than modafinil for treating excessive sleepiness. Its safety profile is comparable, making it a potentially preferred option for patients needing sustained wakefulness.

More Related Videos

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

Related Experiment Videos

Last Updated: Jul 4, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

Area of Science:

  • Pharmacology
  • Sleep Medicine
  • Neurology

Background:

  • Armodafinil is the (R)-enantiomer of modafinil, a wake-promoting agent.
  • It possesses a longer half-life (10-15 hours) compared to racemic modafinil.
  • Approved in 2007, it shares indications with modafinil for excessive sleepiness.

Purpose of the Study:

  • To evaluate the efficacy and safety of armodafinil for excessive sleepiness.
  • To compare wake promotion effects with modafinil.
  • To assess patient preference and compliance.

Main Methods:

  • Clinical trials were conducted in patients with narcolepsy, obstructive sleep apnea syndrome, and shift work disorder.
  • Efficacy was measured by sustained wakefulness and comparison to modafinil doses.
  • Safety and tolerability were assessed throughout the trials.

Main Results:

  • Armodafinil demonstrated enhanced efficacy in promoting wakefulness, sustaining it for longer periods.
  • Lower doses of armodafinil were effective compared to modafinil.
  • The safety profile was consistent with modafinil and well-tolerated by patients.

Conclusions:

  • Armodafinil is an effective treatment for excessive sleepiness with improved duration of action.
  • Its longer half-life may lead to better patient compliance and preference.
  • It represents a valuable therapeutic option alongside modafinil, despite potential market competition.